APO Research
Talk to an analyst

APO RESEARCH · REPORT

Codeine Tablet

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Codeine Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026198 pages

Choose your research edition.

Industry ResearchCodeine Tablet Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Codeine Tablet Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Codeine Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Codeine Tablet Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Codeine Tablet Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Codeine Tablet market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Codeine Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Codeine Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Codeine Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Codeine Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Codeine Tablet include TEVA, Johnson & Johnson, Novartis, Mylan, Taiji, Sanofi Aventis, Pharmaceutical Associates, Medreich and Mallinckrodt, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Codeine Tablet market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Codeine Tablet and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Codeine Tablet sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Codeine Tablet market size, projected growth trends, production technologies, key applications, and end-use industries.

Codeine Tablet Segment by Company

TEVA

Johnson & Johnson

Novartis

Mylan

Taiji

Sanofi Aventis

Pharmaceutical Associates

Medreich

Mallinckrodt

Lannett Company

Laboratoire Riva

Hikma

Cipla

Aristo Pharma GmbH

Apotex

Codeine Tablet Segment by Type

Single-ingredient Codeine

Multi-ingredient Medications

Codeine Tablet Segment by Application

Narcotic Analgesic

Antitussive

Others

Codeine Tablet Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Codeine Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Codeine Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Codeine Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Codeine Tablet market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Codeine Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Codeine Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Codeine Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Codeine Tablet Industry Trends Table 2. Codeine Tablet Industry Drivers Table 3. Codeine Tablet Industry Opportunities and Challenges Table 4. Codeine Tablet Industry Restraints Table 5. Global Codeine Tablet Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Codeine Tablet Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Codeine Tablet Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Codeine Tablet Sales Market Share by Manufacturers Table 9. Global Codeine Tablet Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Codeine Tablet Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Codeine Tablet Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Codeine Tablet Manufacturers, Product Type & Application Table 13. Global Codeine Tablet Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Codeine Tablet by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Single-ingredient Codeine Table 17. Major Manufacturers of Multi-ingredient Medications Table 18. Global Codeine Tablet Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Codeine Tablet Sales by Type (2021-2026) & (K Units) Table 20. Global Codeine Tablet Sales by Type (2027-2032) & (K Units) Table 21. Global Codeine Tablet Sales Market Share by Type (2021-2026) Table 22. Global Codeine Tablet Sales Market Share by Type (2027-2032) Table 23. Global Codeine Tablet Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Codeine Tablet Revenue by Type (2021-2026) & (K Units) Table 25. Global Codeine Tablet Revenue by Type (2027-2032) & (K Units) Table 26. Global Codeine Tablet Revenue Market Share by Type (2021-2026) Table 27. Global Codeine Tablet Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Narcotic Analgesic Table 29. Major Manufacturers of Antitussive Table 30. Major Manufacturers of Others Table 31. Global Codeine Tablet Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Codeine Tablet Sales by Application (2021-2026) & (K Units) Table 33. Global Codeine Tablet Sales by Application (2027-2032) & (K Units) Table 34. Global Codeine Tablet Sales Market Share by Application (2021-2026) Table 35. Global Codeine Tablet Sales Market Share by Application (2027-2032) Table 36. Global Codeine Tablet Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Codeine Tablet Revenue by Application (2021-2026) & (K Units) Table 38. Global Codeine Tablet Revenue by Application (2027-2032) & (K Units) Table 39. Global Codeine Tablet Revenue Market Share by Application (2021-2026) Table 40. Global Codeine Tablet Revenue Market Share by Application (2027-2032) Table 41. Global Codeine Tablet Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Codeine Tablet Sales by Region (2021-2026) & (K Units) Table 43. Global Codeine Tablet Sales Market Share by Region (2021-2026) Table 44. Global Codeine Tablet Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Codeine Tablet Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Codeine Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Codeine Tablet Sales by Country (2021-2026) & (K Units) Table 48. North America Codeine Tablet Sales by Country (2027-2032) & (K Units) Table 49. Europe Codeine Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Codeine Tablet Sales by Country (2021-2026) & (K Units) Table 51. Europe Codeine Tablet Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Codeine Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Codeine Tablet Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Codeine Tablet Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Codeine Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Codeine Tablet Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Codeine Tablet Sales by Country (2027-2032) & (K Units) Table 58. Global Codeine Tablet Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Codeine Tablet Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Codeine Tablet Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Codeine Tablet Revenue Market Share by Region (2021-2026) Table 62. Global Codeine Tablet Revenue Market Share by Region (2027-2032) Table 63. TEVA Company Information Table 64. TEVA Business Overview Table 65. TEVA Codeine Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. TEVA Codeine Tablet Product Portfolio Table 67. TEVA Recent Development Table 68. Johnson & Johnson Company Information Table 69. Johnson & Johnson Business Overview Table 70. Johnson & Johnson Codeine Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Johnson & Johnson Codeine Tablet Product Portfolio Table 72. Johnson & Johnson Recent Development Table 73. Novartis Company Information Table 74. Novartis Business Overview Table 75. Novartis Codeine Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Novartis Codeine Tablet Product Portfolio Table 77. Novartis Recent Development Table 78. Mylan Company Information Table 79. Mylan Business Overview Table 80. Mylan Codeine Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Mylan Codeine Tablet Product Portfolio Table 82. Mylan Recent Development Table 83. Taiji Company Information Table 84. Taiji Business Overview Table 85. Taiji Codeine Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Taiji Codeine Tablet Product Portfolio Table 87. Taiji Recent Development Table 88. Sanofi Aventis Company Information Table 89. Sanofi Aventis Business Overview Table 90. Sanofi Aventis Codeine Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Sanofi Aventis Codeine Tablet Product Portfolio Table 92. Sanofi Aventis Recent Development Table 93. Pharmaceutical Associates Company Information Table 94. Pharmaceutical Associates Business Overview Table 95. Pharmaceutical Associates Codeine Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Pharmaceutical Associates Codeine Tablet Product Portfolio Table 97. Pharmaceutical Associates Recent Development Table 98. Medreich Company Information Table 99. Medreich Business Overview Table 100. Medreich Codeine Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Medreich Codeine Tablet Product Portfolio Table 102. Medreich Recent Development Table 103. Mallinckrodt Company Information Table 104. Mallinckrodt Business Overview Table 105. Mallinckrodt Codeine Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Mallinckrodt Codeine Tablet Product Portfolio Table 107. Mallinckrodt Recent Development Table 108. Lannett Company Company Information Table 109. Lannett Company Business Overview Table 110. Lannett Company Codeine Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Lannett Company Codeine Tablet Product Portfolio Table 112. Lannett Company Recent Development Table 113. Laboratoire Riva Company Information Table 114. Laboratoire Riva Business Overview Table 115. Laboratoire Riva Codeine Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Laboratoire Riva Codeine Tablet Product Portfolio Table 117. Laboratoire Riva Recent Development Table 118. Hikma Company Information Table 119. Hikma Business Overview Table 120. Hikma Codeine Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Hikma Codeine Tablet Product Portfolio Table 122. Hikma Recent Development Table 123. Cipla Company Information Table 124. Cipla Business Overview Table 125. Cipla Codeine Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Cipla Codeine Tablet Product Portfolio Table 127. Cipla Recent Development Table 128. Aristo Pharma GmbH Company Information Table 129. Aristo Pharma GmbH Business Overview Table 130. Aristo Pharma GmbH Codeine Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Aristo Pharma GmbH Codeine Tablet Product Portfolio Table 132. Aristo Pharma GmbH Recent Development Table 133. Apotex Company Information Table 134. Apotex Business Overview Table 135. Apotex Codeine Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Apotex Codeine Tablet Product Portfolio Table 137. Apotex Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Codeine Tablet Distributors List Table 141. Codeine Tablet Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Codeine Tablet Product Image Figure 2. Global Codeine Tablet Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Codeine Tablet Market Size (2021-2032) & (US$ Million) Figure 4. Global Codeine Tablet Sales (2021-2032) & (K Units) Figure 5. Global Codeine Tablet Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Codeine Tablet Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Single-ingredient Codeine Image Figure 9. Multi-ingredient Medications Image Figure 10. Global Codeine Tablet Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Codeine Tablet Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Codeine Tablet Sales Market Share by Type (2021-2032) Figure 13. Global Codeine Tablet Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Codeine Tablet Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Codeine Tablet Revenue Market Share by Type (2021-2032) Figure 16. Narcotic Analgesic Image Figure 17. Antitussive Image Figure 18. Others Image Figure 19. Global Codeine Tablet Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Codeine Tablet Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Codeine Tablet Sales Market Share by Application (2021-2032) Figure 22. Global Codeine Tablet Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Codeine Tablet Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Codeine Tablet Revenue Market Share by Application (2021-2032) Figure 25. North America Codeine Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Codeine Tablet Sales Market Share by Country (2021-2032) Figure 27. U.S. Codeine Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Codeine Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Codeine Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Codeine Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Codeine Tablet Sales Market Share by Country (2021-2032) Figure 32. Germany Codeine Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Codeine Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Codeine Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Codeine Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Codeine Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Codeine Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Codeine Tablet Sales Market Share by Country (2021-2032) Figure 39. China Codeine Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Codeine Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Codeine Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Codeine Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Codeine Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Codeine Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Codeine Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Codeine Tablet Sales Market Share by Country (2021-2032) Figure 47. Brazil Codeine Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Codeine Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Codeine Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Codeine Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Codeine Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Codeine Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Codeine Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Codeine Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Codeine Tablet Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Codeine Tablet Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Codeine Tablet Revenue (2021-2032) & (US$ Million) Figure 58. North America Codeine Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Codeine Tablet Revenue (2021-2032) & (US$ Million) Figure 60. Europe Codeine Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Codeine Tablet Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Codeine Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Codeine Tablet Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Codeine Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Codeine Tablet Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Codeine Tablet Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Single-ingredient Codeine
  • Multi-ingredient Medications
Applications
  • Narcotic Analgesic
  • Antitussive
  • Others
Companies covered
  • TEVA
  • Johnson & Johnson
  • Novartis
  • Mylan
  • Taiji
  • Sanofi Aventis
  • Pharmaceutical Associates
  • Medreich
  • Mallinckrodt
  • Lannett Company
  • Laboratoire Riva
  • Hikma
  • Cipla
  • Aristo Pharma GmbH
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Codeine Tablet Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Codeine Tablet Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Codeine Tablet Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Codeine Tablet Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Codeine Tablet Market Dynamics
  1. 2.1 Codeine Tablet Industry Trends
  2. 2.2 Codeine Tablet Industry Drivers
  3. 2.3 Codeine Tablet Industry Opportunities and Challenges
  4. 2.4 Codeine Tablet Industry Restraints
3 Codeine Tablet Market by Manufacturers
  1. 3.1 Global Codeine Tablet Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Codeine Tablet Sales by Manufacturers (2021-2026)
  3. 3.3 Global Codeine Tablet Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Codeine Tablet Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Codeine Tablet Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Codeine Tablet Manufacturers, Product Type & Application
  7. 3.7 Global Codeine Tablet Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Codeine Tablet Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Codeine Tablet Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Codeine Tablet Tier 1, Tier 2, and Tier 3
4 Codeine Tablet Market by Type
  1. 4.1 Codeine Tablet Type Introduction
  2. 4.1.1 Single-ingredient Codeine
  3. 4.1.2 Multi-ingredient Medications
  4. 4.2 Global Codeine Tablet Sales by Type
  5. 4.2.1 Global Codeine Tablet Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Codeine Tablet Sales by Type (2021-2032)
  7. 4.2.3 Global Codeine Tablet Sales Market Share by Type (2021-2032)
  8. 4.3 Global Codeine Tablet Revenue by Type
  9. 4.3.1 Global Codeine Tablet Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Codeine Tablet Revenue by Type (2021-2032)
  11. 4.3.3 Global Codeine Tablet Revenue Market Share by Type (2021-2032)
5 Codeine Tablet Market by Application
  1. 5.1 Codeine Tablet Application Introduction
  2. 5.1.1 Narcotic Analgesic
  3. 5.1.2 Antitussive
  4. 5.1.3 Others
  5. 5.2 Global Codeine Tablet Sales by Application
  6. 5.2.1 Global Codeine Tablet Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Codeine Tablet Sales by Application (2021-2032)
  8. 5.2.3 Global Codeine Tablet Sales Market Share by Application (2021-2032)
  9. 5.3 Global Codeine Tablet Revenue by Application
  10. 5.3.1 Global Codeine Tablet Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Codeine Tablet Revenue by Application (2021-2032)
  12. 5.3.3 Global Codeine Tablet Revenue Market Share by Application (2021-2032)
6 Global Codeine Tablet Sales by Region
  1. 6.1 Global Codeine Tablet Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Codeine Tablet Sales by Region (2021-2032)
  3. 6.2.1 Global Codeine Tablet Sales by Region (2021-2026)
  4. 6.2.2 Global Codeine Tablet Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Codeine Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Codeine Tablet Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Codeine Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Codeine Tablet Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Codeine Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Codeine Tablet Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Codeine Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Codeine Tablet Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Codeine Tablet Revenue by Region
  1. 7.1 Global Codeine Tablet Revenue by Region
  2. 7.1.1 Global Codeine Tablet Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Codeine Tablet Revenue by Region (2021-2026)
  4. 7.1.3 Global Codeine Tablet Revenue by Region (2027-2032)
  5. 7.1.4 Global Codeine Tablet Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Codeine Tablet Revenue (2021-2032)
  8. 7.2.2 North America Codeine Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Codeine Tablet Revenue (2021-2032)
  11. 7.3.2 Europe Codeine Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Codeine Tablet Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Codeine Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Codeine Tablet Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Codeine Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 TEVA
  2. 8.1.1 TEVA Company Information
  3. 8.1.2 TEVA Business Overview
  4. 8.1.3 TEVA Codeine Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 TEVA Codeine Tablet Product Portfolio
  6. 8.1.5 TEVA Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Codeine Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Codeine Tablet Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Codeine Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Codeine Tablet Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Codeine Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Codeine Tablet Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Taiji
  26. 8.5.1 Taiji Company Information
  27. 8.5.2 Taiji Business Overview
  28. 8.5.3 Taiji Codeine Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Taiji Codeine Tablet Product Portfolio
  30. 8.5.5 Taiji Recent Developments
  31. 8.6 Sanofi Aventis
  32. 8.6.1 Sanofi Aventis Company Information
  33. 8.6.2 Sanofi Aventis Business Overview
  34. 8.6.3 Sanofi Aventis Codeine Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sanofi Aventis Codeine Tablet Product Portfolio
  36. 8.6.5 Sanofi Aventis Recent Developments
  37. 8.7 Pharmaceutical Associates
  38. 8.7.1 Pharmaceutical Associates Company Information
  39. 8.7.2 Pharmaceutical Associates Business Overview
  40. 8.7.3 Pharmaceutical Associates Codeine Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pharmaceutical Associates Codeine Tablet Product Portfolio
  42. 8.7.5 Pharmaceutical Associates Recent Developments
  43. 8.8 Medreich
  44. 8.8.1 Medreich Company Information
  45. 8.8.2 Medreich Business Overview
  46. 8.8.3 Medreich Codeine Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Medreich Codeine Tablet Product Portfolio
  48. 8.8.5 Medreich Recent Developments
  49. 8.9 Mallinckrodt
  50. 8.9.1 Mallinckrodt Company Information
  51. 8.9.2 Mallinckrodt Business Overview
  52. 8.9.3 Mallinckrodt Codeine Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mallinckrodt Codeine Tablet Product Portfolio
  54. 8.9.5 Mallinckrodt Recent Developments
  55. 8.10 Lannett Company
  56. 8.10.1 Lannett Company Company Information
  57. 8.10.2 Lannett Company Business Overview
  58. 8.10.3 Lannett Company Codeine Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Lannett Company Codeine Tablet Product Portfolio
  60. 8.10.5 Lannett Company Recent Developments
  61. 8.11 Laboratoire Riva
  62. 8.11.1 Laboratoire Riva Company Information
  63. 8.11.2 Laboratoire Riva Business Overview
  64. 8.11.3 Laboratoire Riva Codeine Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Laboratoire Riva Codeine Tablet Product Portfolio
  66. 8.11.5 Laboratoire Riva Recent Developments
  67. 8.12 Hikma
  68. 8.12.1 Hikma Company Information
  69. 8.12.2 Hikma Business Overview
  70. 8.12.3 Hikma Codeine Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hikma Codeine Tablet Product Portfolio
  72. 8.12.5 Hikma Recent Developments
  73. 8.13 Cipla
  74. 8.13.1 Cipla Company Information
  75. 8.13.2 Cipla Business Overview
  76. 8.13.3 Cipla Codeine Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cipla Codeine Tablet Product Portfolio
  78. 8.13.5 Cipla Recent Developments
  79. 8.14 Aristo Pharma GmbH
  80. 8.14.1 Aristo Pharma GmbH Company Information
  81. 8.14.2 Aristo Pharma GmbH Business Overview
  82. 8.14.3 Aristo Pharma GmbH Codeine Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Aristo Pharma GmbH Codeine Tablet Product Portfolio
  84. 8.14.5 Aristo Pharma GmbH Recent Developments
  85. 8.15 Apotex
  86. 8.15.1 Apotex Company Information
  87. 8.15.2 Apotex Business Overview
  88. 8.15.3 Apotex Codeine Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Apotex Codeine Tablet Product Portfolio
  90. 8.15.5 Apotex Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Codeine Tablet Value Chain Analysis
  2. 9.1.1 Codeine Tablet Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Codeine Tablet Production Mode & Process
  6. 9.2 Codeine Tablet Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Codeine Tablet Distributors
  9. 9.2.3 Codeine Tablet Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst